Sensitive Urine Immunoassay for Visualization of Lipoarabinomannan for Noninvasive Tuberculosis Diagnosis
ACS Nano · 2023
DOI: 10.1021/acsnano.3c01374 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Piaopiao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Med+X Center for Manufacturing, Department of Radiology, National Clinical Research Center for Geriatrics, West Ch…. Hauptthemen laut MEDLINE: Tuberculosis, HIV Infections, Mycobacterium tuberculosis. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Sichuan University.
Abstract (Originalsprache)
Lipoarabinomannan (LAM) is a prospective noninvasive biomarker for tuberculosis (TB) diagnosis. Here, we report a visual immunoassay of high sensitivity for detecting LAM in urine samples toward TB diagnosis. This method uses a DNA-linked immunosorbent of LAM, followed by a transduction cascade into amplified visual signals using quantum dots (QDs) and calcein reaction with Cu2+ and copper nanoparticles (Cu NPs). The limit of detection (LOD) for LAM in the urine reaches 2.5 fg/mL and 25 fg/mL using a fluorometer and length readouts on strips, respectively, demonstrating an ultrahigh sensitivity. The clinical validation of the proposed assay was performed with 147 HIV-negative clinical urine specimens. The results show the sensitivity of test is 94.1% (16/17) for confirmed TB (culture-positive) and 85% (51/60) for unconfirmed TB (clinical diagnosis without positive culture results), respectively, when the test cutoff value is 40 fg/mL for TB. Its specificity is 89.2% (25/28) in non-TB and nontuberculous mycobacterial patients. The area under the curve (AUC) was 0.86 when controls were non-TB and LTBI patients, while the AUC was 0.92 when controls were only non-TB patients. This highly sensitive visual immunoassay of LAM has shown potential for noninvasive diagnosis of TB using urine samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Med+X Center for Manufacturing, Department of Radiology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
ORCID-Profile: Piaopiao Chen, Walter Hu, Binwu Ying
Förderung
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- Sichuan University
- Department of Science and Technology of Sichuan Province
- National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University
Zitieren
APA
Chen, P., Meng, Y., Liu, T., Peng, W., Gao, Y., He, Y., Qu, R., Zhang, C., Hu, W., & Ying, B. (2023). Sensitive Urine Immunoassay for Visualization of Lipoarabinomannan for Noninvasive Tuberculosis Diagnosis. ACS Nano. https://doi.org/10.1021/acsnano.3c01374
Vancouver
Chen P, Meng Y, Liu T, Peng W, Gao Y, He Y, et al. Sensitive Urine Immunoassay for Visualization of Lipoarabinomannan for Noninvasive Tuberculosis Diagnosis. ACS Nano. 2023. doi:10.1021/acsnano.3c01374
BibTeX
@article{Chen2023,
author = {Chen, Piaopiao and Meng, Yanming and Liu, Tangyuheng and Peng, Wu and Gao, Yue and He, Yaqin and Qu, Runlian and Zhang, Chunying and Hu, Walter and Ying, Binwu},
title = {Sensitive Urine Immunoassay for Visualization of Lipoarabinomannan for Noninvasive Tuberculosis Diagnosis},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.3c01374}
}
EUVIMED